uu.seUppsala universitets publikasjoner
Endre søk
RefereraExporteraLink to record
Permanent link

Direct link
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Annet format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annet språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf
Targeting against epidermal growth factor receptors: Cellular processing of astatinated EGF after binding to cultured carcinoma cells
Uppsala universitet, Medicinska och farmaceutiska vetenskapsområdet, Medicinska fakulteten, Institutionen för onkologi, radiologi och klinisk immunologi, Enheten för biomedicinsk strålningsvetenskap.ORCID-id: 0000-0001-6120-2683
Uppsala universitet, Medicinska och farmaceutiska vetenskapsområdet, Medicinska fakulteten, Institutionen för onkologi, radiologi och klinisk immunologi, Enheten för biomedicinsk strålningsvetenskap.
Nuclear Physics Institute, Rez, Czech Republic.
Uppsala universitet, Medicinska och farmaceutiska vetenskapsområdet, Medicinska fakulteten, Institutionen för onkologi, radiologi och klinisk immunologi, Enheten för biomedicinsk strålningsvetenskap.
Vise andre og tillknytning
2004 (engelsk)Inngår i: Anticancer Research, ISSN 0250-7005, E-ISSN 1791-7530, Vol. 24, nr 6, s. 4035-4042Artikkel i tidsskrift (Fagfellevurdert) Published
Abstract [en]

BACKGROUND:

The alpha-emitting nuclide 211At is of great interest for radionuclide therapy when coupled to a tumor-targeting biomolecule, e.g. epidermal growth factor (EGF) the receptors of which are overexpressed in many malignancies. However, almost no information concerning the cellular processing of astatinated targeting agents is available.

MATERIALS AND METHODS:

We indirectly astatinated EGF ([211At]-benzoate-EGF) and studied its cellular processing in A-431 carcinoma cells in comparison with data concerning [125I]-benzoate-EGF.

RESULTS:

The biological half-life of astatine (3.5 h) was longer than the half-life of the iodine label (1.5 h). The increase of the half-life was due to longer retention of the internalised astatine radioactivity. The maximum accumulation for the astatine label occurred later (4-6h) than that for the iodine label (2-4h), indicating a slower excretion of astatine that was confirmed in experiment with 211At/1251-benzoate-EGF.

CONCLUSION:

The long retention of astatine might be advantageous for radionuclide therapy.

sted, utgiver, år, opplag, sider
2004. Vol. 24, nr 6, s. 4035-4042
Emneord [en]
Astatine/chemistry/metabolism/*pharmacokinetics, Carcinoma/*metabolism/radiotherapy, Cell Line; Tumor, Cell Membrane/metabolism, Epidermal Growth Factor/metabolism/*pharmacokinetics, Epithelioid Cells/metabolism/pathology, Half-Life, Humans, Iodobenzoates/metabolism/pharmacokinetics, Radiopharmaceuticals/metabolism/*pharmacokinetics, Receptor; Epidermal Growth Factor/*metabolism
HSV kategori
Identifikatorer
URN: urn:nbn:se:uu:diva-72882PubMedID: 15736449OAI: oai:DiVA.org:uu-72882DiVA, id: diva2:100793
Tilgjengelig fra: 2007-03-09 Laget: 2007-03-09 Sist oppdatert: 2017-12-14bibliografisk kontrollert

Open Access i DiVA

Fulltekst mangler i DiVA

Andre lenker

PubMedhttp://ar.iiarjournals.org/content/24/6/4035.long

Personposter BETA

Orlova, AnnaSjöström, AnnaLundqvist, HansCarlsson, JorgenTolmachev, Vladimir

Søk i DiVA

Av forfatter/redaktør
Orlova, AnnaSjöström, AnnaLundqvist, HansCarlsson, JorgenTolmachev, Vladimir
Av organisasjonen
I samme tidsskrift
Anticancer Research

Søk utenfor DiVA

GoogleGoogle Scholar

pubmed
urn-nbn

Altmetric

pubmed
urn-nbn
Totalt: 838 treff
RefereraExporteraLink to record
Permanent link

Direct link
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Annet format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annet språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf